|
| 38030749 | Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. | Br J Cancer | 2024 |
| 38030749 | Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. | Br J Cancer | 2024 |
| 37838650 | Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy. | Ann Surg Oncol | 2024 |
| 37925057 | Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation. | Mod Pathol | 2024 |
| 37973648 | Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment. | Ann Surg Oncol | 2024 |
| 38050371 | Fetal Type Morphologies Suggest the Presence of DICER1 Hotspot Mutations in Non-small Cell Lung Cancer. | Am J Surg Pathol | 2024 |
| 37957483 | Functional and phenotypic consequences of an unusual inversion in MSH2. | Fam Cancer | 2024 |
| 37957483 | Functional and phenotypic consequences of an unusual inversion in MSH2. | Fam Cancer | 2024 |
| 37838650 | Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy. | Ann Surg Oncol | 2024 |
| 38050371 | Fetal Type Morphologies Suggest the Presence of DICER1 Hotspot Mutations in Non-small Cell Lung Cancer. | Am J Surg Pathol | 2024 |
| 37973648 | Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment. | Ann Surg Oncol | 2024 |
| 37925057 | Dedifferentiated and Undifferentiated Ovarian Carcinoma: An Aggressive and Molecularly Distinct Ovarian Tumor Characterized by Frequent SWI/SNF Complex Inactivation. | Mod Pathol | 2024 |
| 35039446 | Long-term tumour dormancy in a <i>BRCA1</i> heterozygote. | J Med Genet | 2023 |
| 36240479 | Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset. | J Clin Oncol | 2023 |
| 38019076 | Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation. | Cancer Res Commun | 2023 |
| 37638828 | A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma. | Pediatr Blood Cancer | 2023 |
| 38084291 | Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant Curation. | Hum Mutat | 2023 |
| 37345679 | Unusual Aspects of Small Cell Carcinoma of the Ovary of Hypercalcaemic Type: Retained SMARCA4 Immunohistochemical Staining and Positive Staining With TLE1. | Am J Surg Pathol | 2023 |
| 36969007 | Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases. | Front Oncol | 2023 |
| 36833203 | Molecular Genetic Characteristics of <i>FANCI</i>, a Proposed New Ovarian Cancer Predisposing Gene. | Genes (Basel) | 2023 |
| 36586540 | Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency. | Gastroenterology | 2023 |
| 37210563 | Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss. | Nat Commun | 2023 |
| 37209596 | Germline EGFR c.2527GÂ >Â A (p.V843I) variant and familial lung cancer. | Lung Cancer | 2023 |
| 36966138 | Genomic characterization of DICER1-associated neoplasms uncovers molecular classes. | Nat Commun | 2023 |
| 36583307 | Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs. | Am J Surg Pathol | 2023 |
| 37333613 | DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility. | NAR Cancer | 2023 |
| 37460202 | Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes. | J Med Genet | 2023 |
| 37015678 | Moving breast cancer susceptibility gene testing into the mainstream. | Med J Aust | 2023 |
| 36813544 | Germline pathogenic <i>SMARCA4</i> variants in neuroblastoma. | J Med Genet | 2023 |
| 36571512 | The risks of cancer in older women with BRCA pathogenic variants: How far have we come? | Cancer | 2023 |
| 36944611 | Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca<sup>2+</sup> flux to mitochondria. | Nat Commun | 2023 |
| 37248399 | Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis. | Fam Cancer | 2023 |
| 36863945 | miRNA biogenesis and inherited disorders: clinico-molecular insights. | Trends Genet | 2023 |
| 37114246 | Germline Platelet-derived growth factor receptor beta p.R987W pathogenic variant in 2 children with brain tumors. | Neurooncol Adv | 2023 |
| 36786840 | SMARCA4-associated schwannomatosis. | Acta Neuropathol | 2023 |
| 37490054 | Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 35039446 | Long-term tumour dormancy in a <i>BRCA1</i> heterozygote. | J Med Genet | 2023 |
| 38084291 | Specifications of the ACMG/AMP Variant Classification Guidelines for Germline <i>DICER1</i> Variant Curation. | Hum Mutat | 2023 |
| 38019076 | Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation. | Cancer Res Commun | 2023 |
| 37490054 | Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 37638828 | A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma. | Pediatr Blood Cancer | 2023 |
| 37460202 | Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes. | J Med Genet | 2023 |
| 37345679 | Unusual Aspects of Small Cell Carcinoma of the Ovary of Hypercalcaemic Type: Retained SMARCA4 Immunohistochemical Staining and Positive Staining With TLE1. | Am J Surg Pathol | 2023 |
| 37248399 | Reclassification of two germline DICER1 splicing variants leads to DICER1 syndrome diagnosis. | Fam Cancer | 2023 |
| 37015678 | Moving breast cancer susceptibility gene testing into the mainstream. | Med J Aust | 2023 |
| 37210563 | Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss. | Nat Commun | 2023 |
| 37114246 | Germline Platelet-derived growth factor receptor beta p.R987W pathogenic variant in 2 children with brain tumors. | Neurooncol Adv | 2023 |
| 36944611 | Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca<sup>2+</sup> flux to mitochondria. | Nat Commun | 2023 |
| 37209596 | Germline EGFR c.2527GÂ >Â A (p.V843I) variant and familial lung cancer. | Lung Cancer | 2023 |
| 37333613 | DICER1 platform domain missense variants inhibit miRNA biogenesis and lead to tumor susceptibility. | NAR Cancer | 2023 |